Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 10:42 PM
Ignite Modification Date:
2025-12-25 @ 8:13 PM
NCT ID:
NCT02567435
Pre Assignment Details:
Among the 325 patients that enrolled, 4 patients were ineligible, 11 eligible patients were enrolled onto the feasibility phase (with 1 transferred to Regimen C), and 310 eligible patients were randomized and enrolled onto the efficacy phase (with 2 transferred to Regimen C). 13 randomized eligible patients were not analyzed (not evaluable due to FOXO1 diagnosis or amendment after study activated).
Recruitment Details:
This study was opened for enrollment on May 23, 2016, and was temporarily closed to accrual on September 23, 2016 for feasibility review. The study was re-opened for enrollment on January 2, 2018. The study was temporarily closed again on August 22, 2018 and re-opened on December 31, 2018 with the addition of maintenance therapy. The study is closed to accrual since 1/6/2022.
Study:
NCT02567435
Study Brief:
Results Section:
NCT02567435